Prophylaxis of intravenous immunoglobulin and acyclovir in perinatal varicella

Yhu Chering Huang, Tzou Yien Lin, Yi Jane Lin, Rey In Lien, Yi Hong Chou

研究成果: 雜誌貢獻文章同行評審

37 引文 斯高帕斯(Scopus)


Maternal chickenpox around the time of delivery can cause severe and even fatal illness in the newborn but an effectively preventive method has not yet been established. We proposed that a combination of intravenous immunoglobulin (IVIG) and acyclovir (ACV) intravenously could effectively prevent perinatal varicella. A group of 24 newborn infants whose mother had developed a varicella rash within 14 days before and after delivery were studied. Some 15 infants whose mothers' rash appeared within 7 days before and 5 days after delivery were categorised as an at-risk group and received IVIG prophylaxis (500 mg/kg) administered soon after birth or post-natal contact either alone or with intravenous acyclovir (5 mg/kg every 8 h) for a total of 5 days starting from 7 days after the onset of maternal rash. Of four infants receiving IVIG alone, two developed clinical varicella. None of ten infants receiving both IVIG and ACV contracted varicella. One infant receiving ACV alone had no varicella vesicles either. Of nine infants in the not at-risk group four had undetectable varicella-zoster virus antibody on admission and developed clinical varicella subsequently. Conclusion: The combination of intravenous immunoglobulin given soon after birth and prophylactic acyclovir intravenously administered 7 days after the onset of maternal rash can effectively prevent perinatal varicella.
頁(從 - 到)91-94
期刊European Journal of Pediatrics
出版狀態已發佈 - 2001

ASJC Scopus subject areas

  • 兒科、圍產兒和兒童健康


深入研究「Prophylaxis of intravenous immunoglobulin and acyclovir in perinatal varicella」主題。共同形成了獨特的指紋。